Arkolith/Insider Trading/FHTX/Form 4

Agresta Samuel

Chief Medical OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Aug 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2023Option exercise(M)311K$3.72$1.2M311K
Aug 16, 2023Sell(S)311K$8.25$2.6M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 16, 2023Option exercise(M)311K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-006433) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Foghorn Therapeutics Inc.

Build

Ask your agent about FHTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001562180-23-006433"
Ask your agent
Use Arkolith to summarize insider buying and selling at Foghorn Therapeutics Inc.
over the last 90 days and cite the filings.